FDA Inks Class II Designation For Embryo Viability Tests
This article was originally published in The Gray Sheet
The agency set a class II with special controls designation for assisted reproduction embryo image assessment systems in a Feb. 26 final order, following the de novo decision for Auxogyn’s Eeva system last summer.
You may also be interested in...
US regulators are proposing makers of fertility assistant devices first test their products on mice embryos in the lab to better understand any potential toxicity risk to human embryos and the viability of the fetus.
Japanese major links with new partners in European consortium to progress first-in-class molecule for multiple hematological malignancies.
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.